Skip to main content Help with accessibility Skip to main navigation

ROFLUMILAST (Daxas®▼) for COPD

CCG Approval Status:

Date Added: 31 - Jul - 2019
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of ROFLUMILAST tablets (Daxas®▼) following specialist recommendation as an add-on to bronchodilator therapy, for treating severe chronic obstructive pulmonary disease in adults with chronic bronchitis (in accordance with NICE TA461).

Static